Bristol-Myers Squibb Reports Q2 2026 Financial Results

What Happened

• On July 30, 2026, Bristol-Myers Squibb Company (BMY) announced its financial results for the second quarter of 2026 by issuing an earnings press release and posting a presentation on its website. The materials were made available in advance of the company's conference call and webcast scheduled for 8:15 a.m. Eastern time that day.

Key Details

• Filing date: July 30, 2026 (Form 8-K Items 2.02 and 7.01).
• Materials posted: an Earnings Press Release and a Bristol Myers Presentation on www.bms.com.
• Purpose: Announce Q2 2026 financial results and provide presentation materials for the earnings call/webcast at 8:15 a.m. ET.
• The press release and presentation were furnished with the Form 8-K (exhibits referenced in the filing).

Why It Matters

• These documents are the company’s official public disclosure of its quarterly results—investors should review the press release and presentation for revenue, earnings, guidance, and any management commentary that could affect BMY’s near-term outlook. The posting and conference call provide the primary sources for measuring quarterly performance and assessing implications for shares, portfolio positioning, and analyst expectations.